63 related articles for article (PubMed ID: 8440080)
21. Calbindin D-28k and parvalbumin immunoreactivity in the frontal cortex in patients with frontal lobe dementia of non-Alzheimer type associated with amyotrophic lateral sclerosis.
Ferrer I; Tuñón T; Serrano MT; Casas R; Alcántara S; Zújar MJ; Rivera RM
J Neurol Neurosurg Psychiatry; 1993 Mar; 56(3):257-61. PubMed ID: 8459241
[TBL] [Abstract][Full Text] [Related]
22. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex.
Desai PP; Ikonomovic MD; Abrahamson EE; Hamilton RL; Isanski BA; Hope CE; Klunk WE; DeKosky ST; Kamboh MI
Neurobiol Dis; 2005 Nov; 20(2):574-82. PubMed ID: 15916898
[TBL] [Abstract][Full Text] [Related]
23. Calbindin D-28K in the nucleus pretectalis superficialis parvicellularis of Salmo gairdneri: an immunocytochemical study.
Cuadrado MI
Arch Ital Biol; 1992 Jan; 130(1):11-8. PubMed ID: 1610264
[TBL] [Abstract][Full Text] [Related]
24. Parvalbumin immunoreactive neurons in normal human temporal neocortex and in patients with Alzheimer's disease.
Ferrer I; Soriano E; Tuñón T; Fonseca M; Guionnet N
J Neurol Sci; 1991 Dec; 106(2):135-41. PubMed ID: 1802961
[TBL] [Abstract][Full Text] [Related]
25. Double bouquet cell axons in the human temporal neocortex: relationship to bundles of myelinated axons and colocalization of calretinin and calbindin D-28k immunoreactivities.
del Rio MR; DeFelipe J
J Chem Neuroanat; 1997 Oct; 13(4):243-51. PubMed ID: 9412906
[TBL] [Abstract][Full Text] [Related]
26. Interstitial cells subjacent to the entorhinal region expressing somatostatin-28 immunoreactivity are susceptible to development of Alzheimer's disease-related cytoskeletal changes.
van de Nes JA; Sandmann-Keil D; Braak H
Acta Neuropathol; 2002 Oct; 104(4):351-6. PubMed ID: 12200620
[TBL] [Abstract][Full Text] [Related]
27. Calbindin D-28K-immunoreactivity in the cat diencephalon: an immunocytochemical study.
Coveñas R; De León M; Narváez JA; Aguirre JA; González-Barón S
Arch Ital Biol; 1995 Oct; 133(4):263-72. PubMed ID: 8849317
[TBL] [Abstract][Full Text] [Related]
28. In vivo proton magnetic resonance spectroscopy of the temporal lobe in Alzheimer's disease.
Frederick BD; Lyoo IK; Satlin A; Ahn KH; Kim MJ; Yurgelun-Todd DA; Cohen BM; Renshaw PF
Prog Neuropsychopharmacol Biol Psychiatry; 2004 Dec; 28(8):1313-22. PubMed ID: 15588758
[TBL] [Abstract][Full Text] [Related]
29. GABABR1 receptor protein expression in human mesial temporal cortex: changes in temporal lobe epilepsy.
Muñoz A; Arellano JI; DeFelipe J
J Comp Neurol; 2002 Jul; 449(2):166-79. PubMed ID: 12115687
[TBL] [Abstract][Full Text] [Related]
30. Reduction of vitamin D hormone receptor mRNA levels in Alzheimer as compared to Huntington hippocampus: correlation with calbindin-28k mRNA levels.
Sutherland MK; Somerville MJ; Yoong LK; Bergeron C; Haussler MR; McLachlan DR
Brain Res Mol Brain Res; 1992 Apr; 13(3):239-50. PubMed ID: 1317496
[TBL] [Abstract][Full Text] [Related]
31. Distribution of calbindin D-28k in the entorhinal, perirhinal, and parahippocampal cortices of the macaque monkey.
Suzuki WA; Porteros A
J Comp Neurol; 2002 Sep; 451(4):392-412. PubMed ID: 12210132
[TBL] [Abstract][Full Text] [Related]
32. Calbindin D-28k- and substance P-immunoreactive primary sensory neurons: peripheral projections in chick hindlimbs.
Duc C; Barakat-Walter I; Droz B
J Comp Neurol; 1993 Aug; 334(1):151-8. PubMed ID: 7691900
[TBL] [Abstract][Full Text] [Related]
33. Selective loss of calbindin D28K-immunoreactive neurons in the cortical layer II in brains of Alzheimer's disease: a morphometric study.
Nishiyama E; Ohwada J; Iwamoto N; Arai H
Neurosci Lett; 1993 Dec; 163(2):223-6. PubMed ID: 8309638
[TBL] [Abstract][Full Text] [Related]
34. A light and electron microscopic study of calbindin D-28k immunoreactive double bouquet cells in the human temporal cortex.
del Río MR; DeFelipe J
Brain Res; 1995 Aug; 690(1):133-40. PubMed ID: 7496800
[TBL] [Abstract][Full Text] [Related]
35. Dementia of frontal lobe type and amyotrophy.
Ferrer I
Behav Neurol; 1992; 5(2):87-96. PubMed ID: 24487710
[TBL] [Abstract][Full Text] [Related]
36. Calbindin immunoreactivity alternates with cytochrome c-oxidase-rich zones in some layers of the primate visual cortex.
Celio MR; Schärer L; Morrison JH; Norman AW; Bloom FE
Nature; 1986 Oct 23-29; 323(6090):715-7. PubMed ID: 3022149
[TBL] [Abstract][Full Text] [Related]
37. Reduction of calbindin-28k mRNA levels in Alzheimer as compared to Huntington hippocampus.
Sutherland MK; Wong L; Somerville MJ; Yoong LK; Bergeron C; Parmentier M; McLachlan DR
Brain Res Mol Brain Res; 1993 Apr; 18(1-2):32-42. PubMed ID: 8479289
[TBL] [Abstract][Full Text] [Related]
38. Loss of calbindin-28K immunoreactive neurones from the cortex in Alzheimer-type dementia.
Ichimiya Y; Emson PC; Mountjoy CQ; Lawson DE; Heizmann CW
Brain Res; 1988 Dec; 475(1):156-9. PubMed ID: 3214722
[TBL] [Abstract][Full Text] [Related]
39. Accumulation of calbindin in cortical pyramidal cells with ageing; a putative protective mechanism which fails in Alzheimer's disease.
Greene JR; Radenahmad N; Wilcock GK; Neal JW; Pearson RC
Neuropathol Appl Neurobiol; 2001 Oct; 27(5):339-42. PubMed ID: 11679085
[TBL] [Abstract][Full Text] [Related]
40. Astrocytes in Alzheimer's disease express immunoreactivity to the vaso-constrictor endothelin-1.
Zhang WW; Badonic T; Höög A; Jiang MH; Ma KC; Nie XJ; Olsson Y
J Neurol Sci; 1994 Mar; 122(1):90-6. PubMed ID: 8195809
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
